Vaccitech to Present at Upcoming September Investor conferences
OXFORD, United Kingdom, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced that Bill Enright, Chief Executive Officer, will be presenting at the following investment conferences in September.
Vaccitech Media contacts:
Henry Hodge, Vaccitech (UK)
ITEXPO #TECHSUPERSHOW Expo Hall Open
#TECHSUPERSHOW Expo Hall Grand Opening
I Robot Run the Warehouse